Recent News

• 05.29.2025 - AN2 Therapeutics Announces Poster Presentation Highlighting M. Abscessus Data at 2025 Colorado Mycobacteria Conference
• 05.29.2025 - AN2 Therapeutics Announces Poster Presentation Highlighting M. Abscessus Data at 2025 Colorado Mycobacteria Conference
• 05.13.2025 - AN2 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business and Scientific Highlights
• 05.13.2025 - AN2 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business and Scientific Highlights
• 05.07.2025 - The Citizens Life Sciences Conference
• 05.07.2025 - The Citizens Life Sciences Conference
• 05.01.2025 - AN2 Therapeutics Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study and Outlines Future Milestones from Boron Chemistry Pipeline

Recent Filings

• 05.27.2025 - 8-K Current report
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - EX-99.1 EX-99.1